Foster Dykema Cabot & Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486 | Hold |
10
| – | – | ﹤0.01% | 334 |
|
|
2025
Q1 | $340 | Hold |
10
| – | – | ﹤0.01% | 331 |
|
|
2024
Q4 | $394 | Hold |
10
| – | – | ﹤0.01% | 368 |
|
|
2024
Q3 | $470 | Hold |
10
| – | – | ﹤0.01% | 496 |
|
|
2024
Q2 | $540 | Hold |
10
| – | – | ﹤0.01% | 312 |
|
|
2024
Q1 | $682 | Hold |
10
| – | – | ﹤0.01% | 309 |
|
|
2023
Q4 | $626 | Buy |
+10
| New | +$626 | ﹤0.01% | 271 |
|